Endonovo Therapeutics, Inc. (ENDV)
OID · Healthcare · Biotechnology
Closing price as of 2026-09-10 · Source: TEK2day Finance
Key Metrics
About Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardio chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular, and peripheral artery disease (PAD) and ischemic stroke. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.
Quarterly Financials
| Metric | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | (1.00) | 0.00 | 0.00 |
| Operating Income | (388K) | (360K) | (231K) | (247K) |
| Net Income | (697K) | (669K) | (533K) | (558K) |
| Diluted EPS | N/A | N/A | $0.00 | N/A |
Annual Financials
| Metric | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 73K | 135K | 140K | 10K |
| Gross Profit | 58K | 125K | 132K | 3K |
| Operating Income | (2.2M) | (3.3M) | (2.9M) | (1.6M) |
| Net Income | (3.1M) | (18.5M) | 6.9M | (2.8M) |
| Diluted EPS | $-0.05 | $-0.13 | $0.01 | $0.00 |